![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » PerkinElmer’s Rapid Point-of-Care COVID-19 Test Cleared in Europe
PerkinElmer’s Rapid Point-of-Care COVID-19 Test Cleared in Europe
![PerkinElmer logo](https://www.fdanews.com/ext/resources/test/Device_Images6/PerkinElmer_Logo.gif?t=1601586945&width=430)
PerkinElmer has earned CE mark certification for its rapid COVID-19 Antigen Test, a test that uses nasal or nasopharyngeal swab samples to detect infection.
The immunoassay test provides a positive or negative result in as few as 15 minutes that can be used to quickly inform isolation and treatment decisions.
The diagnostic is designed for professional use as a point-of-care test in clinical and non-clinical settings, including healthcare centers, travel hubs, educational institutions and businesses, PerkinElmer said.
Upcoming Events
-
21Oct